Real-World Data Shows Bivalent COVID-19 Boosters Reduce Hospitalizations and Urgent Care Utilization for Older Adults

December 19, 2022

Two recently published studies have found that inoculation with the new bivalent COVID-19 mRNA boosters by Moderna and Pfizer reduce the rate of hospitalization and urgent care visits. Older adults were particularly protected by the shots, which boasted an efficacy against hospitalization of 83% and 73% compared to unvaccinated older adults and those only receiving two or more doses of the original vaccines, respectively

According to Brenda Goodman, “The study drew its data from 798 patients who were admitted to 22 hospitals in 18 states between September 8 and November 30. Adults 65 and over have always been among the most vulnerable to Covid-19, and current hospitalization data shows that seniors are again being hit the hardest during the latest wave of Covid-19 cases. This wave is being dominated by BQ.1 and BQ.1.1, which are descendants of BA.5. While hospitalizations have begun to rise for all age groups, they are rising faster for seniors.”

To read more, click here.

(Source: CNN, December 16th, 2022)

Share This Story!